If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

Share Price is delayed by 15 minutes
Get Live Data
426.00    6.00 (1.43%)
Bid:
420.00
Ask:
426.00
Spread: 6.00 (1.429%)
Market Cap: £540.49m
NAS Live PriceLast checked at - London Stock Exchange

Intraday North Atl.smlr Share Chart

Statement re shareholder engagement

23 Dec 2021 16:55

RNS Number : 6843W
North Atlantic Smlr Co Inv Tst PLC
23 December 2021
 

North Atlantic Smaller Companies Investment Trust PLC (the "Company")

 

In June this year, immediately following the Company's Annual General Meeting, the Company announced that over 20% of shareholders voting on resolution 16 concerning the waiver of Rule 9 had voted against the resolution. Resolution 16 was put to the Meeting as a resolution of the independent shareholders of the Company. As a result, 9,878,260 of the ordinary shares in issue were eligible to vote on this resolution, these shares not being held by the Concert Party (as defined in the Notice). The waiver of Rule 9 granted by Resolution 16 permitted the Concert Party's interest in the Company's shares to increase from 29.44% to a maximum of 32.71% (in each case representing 4,121,740 ordinary shares) as a result of the share buyback authorised by Resolution 14 without requiring the Concert Party to make a mandatory offer for the other shareholders' shares.

 

Under the FRC's UK Corporate Governance Code, companies receiving such a vote against a resolution should publish, no later than six months after the shareholder meeting, an update on the views received from shareholders and actions taken by the Company. 

 

The majority of the shares in question are held in nominee accounts, many of which rely on shareholder advisory consultants to determine their voting. This means that underlying investors are recommended to vote against share buybacks in principle as the shareholder advisory consultants are concerned about what they see as the Concert Party's potential creeping control of the Company. Whilst this is a valid concern for a trading company, we do not believe this is so for an investment trust.

 

We have been working to engage with the underlying shareholders and will continue to do so. In at least one case we found that the underlying shareholder, once they had been made aware that the nominee shareholder had voted their shares against the resolution, had tried to change this to vote in favour but found it was too late to do so. In the meantime, the directors believe that it is overwhelmingly in the best interest of all shareholders that the buyback programme continues. Based on the conversations we have had so far we anticipate that a considerable number of previously dissenting shareholders will support similar resolutions in future.

 

 

Contact:

 

Jane Muir

For Derringtons Limited

Company Secretary

020 8819 6486

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRQXLFLFLLEFBF
Date   Source Headline
26th Jun 20182:50 pmRNSResult of AGM
13th Jun 20184:35 pmRNSHolding(s) in Company
11th Jun 201810:49 amRNSNet Asset Value(s)
23rd May 201810:19 amRNSAnnual Financial Report
14th May 201812:34 pmRNSNet Asset Value(s)
11th May 20184:56 pmRNSFinal Results
27th Apr 201810:15 amRNSHolding(s) in Company
18th Apr 20182:38 pmRNSHolding(s) in Company
11th Apr 201810:47 amRNSNet Asset Value(s)
15th Mar 20184:28 pmRNSNet Asset Value(s)
15th Feb 20183:02 pmRNSDirector/PDMR Shareholding
12th Feb 201811:28 amRNSNet Asset Value(s)
24th Jan 201812:08 pmRNSHolding(s) in Company
22nd Jan 201810:35 amRNSHolding(s) in Company
16th Jan 201810:29 amRNSNet Asset Value(s)
12th Dec 20171:05 pmRNSNet Asset Value(s)
14th Nov 201711:04 amRNSNet Asset Value(s)
31st Oct 20175:11 pmRNSDirectorate Change
16th Oct 201711:20 amRNSNet Asset Value(s)
13th Sep 201711:09 amRNSHalf-year Report
12th Sep 20172:05 pmRNSNet Asset Value(s)
15th Aug 201712:17 pmRNSNet Asset Value(s)
27th Jun 20174:20 pmRNSAGM Statement
23rd Jun 20174:42 pmRNSNet Asset Value(s)
1st Jun 201711:21 amRNSAnnual Financial Report
23rd May 20174:30 pmRNSDirector/PDMR Shareholding
23rd May 201710:57 amRNSNet Asset Value(s) - Replacement
19th May 20174:23 pmRNSFinal Results
15th May 201712:57 pmRNSNet Asset Value(s)
18th Apr 20172:02 pmRNSNet Asset Value(s)
5th Apr 201711:36 amRNSDirector/PDMR Shareholding
3rd Apr 20175:20 pmRNSDirector/PDMR Shareholding
30th Mar 201712:20 pmRNSDirector/PDMR Shareholding
28th Mar 201710:43 amRNSDirector/PDMR Shareholding
27th Mar 20176:10 pmRNSDirector/PDMR Shareholding
21st Mar 20171:21 pmRNSDirector/PDMR Shareholding
15th Mar 201710:20 amRNSNet Asset Value(s)
7th Mar 20174:09 pmRNSDirector/PDMR Shareholding
15th Feb 201711:42 amRNSNet Asset Value(s)
18th Jan 20172:46 pmRNSNet Asset Value(s)
11th Jan 201710:52 amRNSTransaction in Own Shares
13th Dec 201610:11 amRNSNet Asset Value(s)
14th Nov 201612:59 pmRNSNet Asset Value(s)
14th Nov 201612:26 pmRNSTransaction in Own Shares
13th Oct 20161:46 pmRNSNet Asset Value(s)
6th Oct 20162:50 pmRNSNotification of Major Interest in Shares
15th Sep 201611:31 amRNSNet Asset Value(s)
14th Sep 20162:40 pmRNSHalf-year Report
10th Aug 201612:17 pmRNSNet Asset Value(s)
13th Jul 201610:30 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.